COVID-19 Outcomes in Underserved Populations: Reaping What One Sows

References

1. 1.↵
   1. Chaudhary S,
   2. Benzaquen S,
   3. Woo JG,
   4. Rubinstein J,
   5. Matta A,
   6. Albano J,
   7. et al

   . Clinical characteristics, respiratory mechanics and outcomes in critically ill subjects with COVID-19 infection in an underserved urban population. Respir Care 2021;66(6):897-908.
2. 2.↵
   1. Horby P,
   2. Lim WS,
   3. Emberson JR,
   4. Mafham M,
   5. Bell JL,
   6. et al

   RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693-704.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Horby PW,
   2. Pessoa-Amorim G,
   3. Peto L,
   4. Brightling CE,
   5. Sarkar R,
   6. et al

   RECOVERY Collaborative Group, Horby PW, Pessoa-Amorim G, Peto L, Brightling CE, Sarkar R, et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. medRxiv 2021 [Epub ahead of print].
4. 4.↵
   1. Attaway AH,
   2. Scheraga RG,
   3. Bhimraj A,
   4. Biehl M,
   5. Hatipoğlu U

   . Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ 2021;372:n436.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Cummings MJ,
   2. Baldwin MR,
   3. Abrams D,
   4. Jacobson SD,
   5. Meyer BJ,
   6. Balough EM,
   7. et al

   . Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395(10239):1763-1770.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Ziehr DR,
   2. Alladina J,
   3. Petri CR,
   4. Maley JH,
   5. Moskowitz Ari,
   6. Medoff BD,
   7. et al

   . Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med 2020;201(12):1560-1564.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Ferrando C,
   2. Suarez-Sipmann F,
   3. Mellado-Artigas R,
   4. Hernández M,
   5. Gea A,
   6. Arruti E,
   7. et al

   . Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 2020;46(12):2200-2211.

   OpenUrl
8. 8.↵
   1. Schenck EJ,
   2. Hoffman K,
   3. Goyal P,
   4. Choi J,
   5. Torres L,
   6. Rajwani K,
   7. et al

   . Respiratory mechanics and gas exchange in COVID-19-associated respiratory failure. Ann Am Thorac Soc 2020;17(9):1158-1161.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Bhatraju PK,
   2. Ghassemieh BJ,
   3. Nichols M,
   4. Kim R,
   5. Jerome KR,
   6. Nalla AK,
   7. et al

   . Covid-19 in critically ill patients in the Seattle region: a case series. N Engl J Med 2020;382(21):2012-2022.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Auld SC,
    2. Caridi-Scheible M,
    3. Blum JM,
    4. Robichaux C,
    5. Kraft C,
    6. Jacob JT,
    7. et al

    . ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med 2020;48(9):e799-e804.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Price-Haywood EG,
    2. Burton J,
    3. Fort D,
    4. Seoane L

    . Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med 2020;382(26):2534-2543.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Wadhera RK,
    2. Wadhera P,
    3. Gaba P,
    4. Figueroa JF,
    5. Joynt Maddox KE,
    6. Yeh RW,
    7. et al

    . Variation in COVID-19 hospitalizations and deaths across New York City boroughs. JAMA 2020;323(21):2192-2195.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Dalsania AK,
    2. Fastiggi MJ,
    3. Kahlam A,
    4. Shah R,
    5. Patel K,
    6. Shiau S,
    7. et al

    . The relationship between social determinants of health and racial disparities in COVID-19 mortality. J Racial Ethn Heal Disparities 2021 [Epub ahead of print].
14. 14.↵
    1. Krishnamoorthy G,
    2. Arsene C,
    3. Jena N,
    4. Mogulla SM,
    5. Coakley R,
    6. Khine J,
    7. et al

    . Racial disparities in COVID-19 hospitalizations do not lead to disparities in outcomes. Public Health 2021;190:93-98.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gupta R,
    2. Agrawal R,
    3. Bukhari Z,
    4. Jabbar A,
    5. Wang D,
    6. Diks J,
    7. et al

    . Higher comorbidities and early death in hospitalized African-American patients with Covid-19. BMC Infect Dis 2021;21(1):78.

    OpenUrl
16. 16.↵
    1. Zelner J,
    2. Trangucci R,
    3. Naraharisetti R,
    4. Cao A,
    5. Malosh R,
    6. Broen K,
    7. et al

    . Racial disparities in coronavirus disease 2019 (COVID-19) mortality are driven by unequal infection risks. Clin Infect Dis 2021;72(5):e88-e95.

    OpenUrl
17. 17.↵
    1. Webb Hooper M,
    2. Nápoles AM,
    3. Pérez-Stable EJ

    . COVID-19 and racial/ethnic disparities. JAMA 2020;323(24):2466-2467.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Mody A,
    2. Pfeifauf K,
    3. Geng EH

    . Using Lorenz curves to measure racial inequities in COVID-19 testing. JAMA Netw Open 2021;4(1):e2032696.

    OpenUrl
19. 19.↵
    1. Aleligne YK,
    2. Appiah D,
    3. Ebong IA

    . Racial disparities in coronavirus disease 2019 (COVID-19) outcomes. Curr Opin Cardiol 2021;36(3):360-366.

    OpenUrl
20. 20.↵
    1. Milner A,
    2. Jumbe S

    . Using the right words to address racial disparities in COVID-19. Lancet Public Heal 2020;5(8):e419-e420.

    OpenUrl